With a market cap of has a large market cap size. Allergan plc (NYSE: AGN) has been on the stock market since its IPO date on the 2/17/1993. Allergan plc is in the Drugs – Generic industry and Healthcare sector. Average volume for Allergan plc, is 3609.77, and so far today it has a volume of 892103. Performance year to date since the 2/17/1993 is -22.36%.
To help you determine whether Allergan plc is undervalued the following values will help you decide. P/E is *TBA and forward P/E is 14.02. PEG perhaps more useful shows that Allergan plc has a value for PEG of *TBA. P/S ratio is 5.93 and the P/B ratio is 1.32. The P/Cash and P/Free cash flow is 42.51 and *TBA respectively.
At the current price Allergan plc is trading at, 245.57 (1.21% today), Allergan plc has a dividend yield of 0.08%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is -5.63, and this is looking to grow in the next year to 21.91% after growing 23.00% this past year. EPS growth quarter over quarter is 86.30%, and 48.10% for sales growth quarter over quarter.
The number of shares outstanding is 398.33, and the number of shares float is 394.89. The senior management bring insider ownership to 0.10%, and institutional ownership is at 89.90%. The float short is 1.47%, with the short ratio at a value of 1.61. Management has seen a return on assets of *TBA, and also a return on investment of -1.30%.
The ability for Allergan plc, to deal with debt, means it current ratio is 1, and quick ratio is 0.9. Long term debt/equity is 0.53 and total debt/equity is 0.59. In terms of margins, Allergan plc has a gross margin of 71.80%, with its operating margin at *TBA, and Allergan plc has a profit margin of *TBA.
The 52 week high is -27.85%, with 25.61% being its 52 week low. The 20 day simple moving average is 4.62% and the 200 day simple moving average is -8.83%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.